A Study to Learn if There is a Difference in the Blood Levels of Acetylsalicylic Acid When Taken as Different Chewable Tablets on an Empty Stomach by Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 26, 2025

Primary Completion Date

April 6, 2025

Study Completion Date

April 6, 2025

Conditions

BioequivalenceHealthy VolunteersPlatelet Aggregation Inhibition

Interventions

DRUG

Acetylsalicylic Acid (Aspirin, BAYE004465, UI1610477)

Chewable tablet, 81mg, oral

DRUG

Acetylsalicylic Acid (BAYE004465, UI1615160)

Chewable tablet, 81 mg, oral

Trial Locations (1)

IPharma, S.A. de C.V., Monterrey